ImmunoGenesis, Inc.

ImmunoGenesis, Inc.

Biotechnology Research 2450 Holcombe Blvd 14 employees
Employees
14
Contacts
4
Emails
4
Phones
2

ImmunoGenesis, Inc. Overview

Headquarters
2450 Holcombe Blvd
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
14
Founded
2019
Funding
5.7M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About ImmunoGenesis, Inc.

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response. We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.

ImmunoGenesis, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

ImmunoGenesis, Inc. Org Chart

Sample employees and titles
Name Title Contact
Paul Blezinger Preclinical R&D Specialist
Email
Jim Barlow
Email
Vicki Sack Founder - Investor - Board Member - Recruiter - Connector
Email Phone
Federica Pericle Cso, Immunogenesis; Analyst, Bluestar Investment Managers
Email Phone

Employees by Management Level

Individual contributor 2 profiles
Executive 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 2

Compare Similar Companies to ImmunoGenesis, Inc.